179072-14-1 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 5-(chloroMethyl)nicotinate hydrochloride is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique structure allows for the development of new medications with potential therapeutic benefits.
Used in Research Applications:
In the field of scientific research, Methyl 5-(chloroMethyl)nicotinate hydrochloride serves as a valuable compound for studying the properties and mechanisms of action of nicotinate-based drugs. It aids researchers in understanding the interactions of these compounds with biological systems and their potential applications in treating diseases.
Used in Drug Development:
Methyl 5-(chloroMethyl)nicotinate hydrochloride is employed as a precursor in the development of new drugs with improved efficacy and safety profiles. Its versatility in chemical reactions enables the creation of innovative pharmaceutical agents that address unmet medical needs.
Used in Treatment of Various Diseases:
Given its potential applications in the synthesis of therapeutic agents, Methyl 5-(chloroMethyl)nicotinate hydrochloride indirectly contributes to the treatment of a wide range of diseases. Its involvement in drug development may lead to the discovery of novel treatments for conditions that currently lack effective therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 179072-14-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,0,7 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 179072-14:
(8*1)+(7*7)+(6*9)+(5*0)+(4*7)+(3*2)+(2*1)+(1*4)=151
151 % 10 = 1
So 179072-14-1 is a valid CAS Registry Number.
179072-14-1Relevant academic research and scientific papers
THERAPEUTIC INHIBITORY COMPOUNDS
-
Page/Page column 210, (2015/07/16)
The invention provides compounds of Formula I and Formula II: A-B-C-D-E-F-G-J (I) C-D-E-F-G-J (II) wherein A, B, C, D, E, F, G, and J have any of the values defined in the specification, and salts thereof. The compounds are useful for inhibiting plasma kallikrein, and for treating a disease or condition in an animal where inhibition of plasma kallikrein is indicated.
Synthesis biological and biological evaluation of some acyclic pyridine C-nucleosides. Part two
Van Hemel, Johan,Esmans, Eddy L.,De Groot, Alex,Dommisse, Roger A.,Balzarini, Jan M.,De Clercq, Erik D.
, p. 1203 - 1221 (2007/10/03)
3-Bromo-5-(2-hydroxyethylthiomethyl)pyridine (7) was synthesized by reaction of 3-bromo-5-chloromethylpyridine hydrochloride (6) with the mono sodium salt of 2-mercaptoethanol. 3-Bromo-5-hydroxymethylpyridine (10) was, after protection as a silyl ether, c
